English
Home > Products > CAS:58-22-0

China CAS:58-22-0 Manufacturer

To be a result of ours specialty and repair consciousness, our corporation has won a good popularity amid consumers everywhere in the environment for CAS:58-22-0, We warmly welcome prospects, organization associations and mates from everywhere in the earth to get in touch with us and request cooperation for mutual benefits.
CAS:58-22-0, With high quality, reasonable price, on-time delivery and customized & customized services to help customers achieve their goals successfully, our company has got praise in both domestic and foreign markets. Buyers are welcome to contact us.

Related Products

Hot Products

  • Desonide

    Desonide

    Desonide has USP and EP specifications. DMF available.

    CAS:638-94-8

  • Ethinyl Estradiol

    Ethinyl Estradiol

    Ethinyl Estradiol has USP, EP and CP specifications. DMF and GMP available.

    CAS:57-63-6

  • Oseltamivir Phosphate

    Oseltamivir Phosphate

    Oseltamivir Phosphate has CP ,EP and USP specifications. DMF available.

    CAS:204255-11-8

  • Triacetyl-ganciclovir

    Triacetyl-ganciclovir

    Triacetyl-ganciclovir is a Ganciclovir derivative.

    CAS:86357-14-4

  • Misoprostol Tablets 0.2mg*30

    Misoprostol Tablets 0.2mg*30

    Misoprostol Tablets 0.2mg*30
    Indications：Gastric ulcer
  • 16alpha-Hydroxyprednisolone Acetate

    16alpha-Hydroxyprednisolone Acetate

    16alpha-Hydroxyprednisolone Acetate is used to observe interaction of some steroid drugs with β-cyclodextrin polymer to calculate the relative strengh of interaction between the hydrophobicity parameters of the drugs and the strenght of the drug-β-​cyclodextrin polymer.

    CAS:86401-80-1

  • Related Blog
  • Reviews

  • 2022 API Exhibition Qingdao

    August 2022
    Founded by China National Medical Control Bureau (the predecessor of NPMA) in 1968.
    Gathering 97% of Top 100 Chinese pharmaceutical enterprises.
    99% manufactures meets the requirements of GMP.
    Supported by numerous powerful associations in China: CCFDIE, CPIA, CBPIA, CATCM, CNMA, CNPPA, etc.

  • 2022 CPhI Exhibition Shanghai

    CPhI is the undisputed leader in the pharmaceutical industry. CPhI China offers a key access point to the second largest pharma market in the world. The exhibition features over 3,000 companies and incorporates various API showcases like bioLIVE, iCSE, NEX and FDF, creating a comprehensive platform that connects the entire pharmaceutical industry chain in the Asian-Pacific region.

  • 2024 Exhibition Calendar: Connect with Us and Explore New Possibilities!

    Our 2024 Exhibition Calendar has been announced! Come meet our team and explore new business opportunities.We look forward to seeing you there!

  • Are There Any Side Effects or Risks Associated with Levonorgestrel Capsules

    As a leading provider in women's reproductive health, we at Humanwell often receive questions from individuals considering emergency contraception. One of the most frequent and important queries we encounter is about the safety profile of Levonorgestrel Capsules.

  • CPHI China 2026 | June 16-18, Looking forward to meeting you

    CPHI China will be staged at Shanghai New International Expo Center on June 16-18, 2026 together with ICSE & PMEC China,our booth number is W1G20.

  • Is Dutasteride the Most Effective Solution for Hair Loss and Benign Prostatic Hyperplasia

    As a trusted pharmaceutical manufacturer, Humanwell has continuously focused on providing high-quality active pharmaceutical ingredients and healthcare solutions. Among these, Dutasteride has gained significant attention worldwide due to its proven effectiveness in treating benign prostatic hyperplasia (BPH) and its growing application in hair loss management. As more healthcare professionals and consumers seek reliable solutions, understanding how Dutasteride works, its benefits, safety profile, and potential applications becomes increasingly important.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept